Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

Evaluation of the safety and immunogenicity in United Kingdom laboratory workers of a combined Haemophilus influenzae type b and meningococcal capsular group C conjugate vaccine.

Findlow J, Findlow H, Frankland S, Holland A, Holme D, Newton E, Southern J, Waight P, Kaczmarski E, Miller E, Borrow R.

J Occup Med Toxicol. 2014 Jul 16;9:26. doi: 10.1186/1745-6673-9-26. eCollection 2014.

PMID:
25071861
[PubMed]
Free PMC Article
2.

Meningococcal polysaccharide A O-acetylation levels do not impact the immunogenicity of the quadrivalent meningococcal tetanus toxoid conjugate vaccine: results from a randomized, controlled phase III study of healthy adults aged 18 to 25 years.

Lupisan S, Limkittikul K, Sosa N, Chanthavanich P, Bianco V, Baine Y, Van der Wielen M, Miller JM.

Clin Vaccine Immunol. 2013 Oct;20(10):1499-507. doi: 10.1128/CVI.00162-13. Epub 2013 Jul 24.

PMID:
23885033
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt.

Tartof S, Cohn A, Tarbangdo F, Djingarey MH, Messonnier N, Clark TA, Kambou JL, Novak R, Diomandé FV, Medah I, Jackson ML.

PLoS One. 2013 May 9;8(5):e63605. doi: 10.1371/journal.pone.0063605. Print 2013.

PMID:
23671685
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

A randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in children aged 2-10 years.

Vesikari T, Forstén A, Boutriau D, Bianco V, Van der Wielen M, Miller JM.

Hum Vaccin Immunother. 2012 Dec 1;8(12):1882-91. doi: 10.4161/hv.22165. Epub 2012 Oct 2.

PMID:
23032168
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The immunogenicity and safety of an investigational meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate vaccine (ACWY-TT) compared with a licensed meningococcal tetravalent polysaccharide vaccine: a randomized, controlled non-inferiority study.

Dbaibo G, Macalalad N, Aplasca-De Los Reyes MR, Dimaano E, Bianco V, Baine Y, Miller J.

Hum Vaccin Immunother. 2012 Jul;8(7):873-80. doi: 10.4161/hv.20211. Epub 2012 Apr 9.

PMID:
22485050
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Meningococcal conjugate vaccines: optimizing global impact.

Terranella A, Cohn A, Clark T.

Infect Drug Resist. 2011;4:161-9. doi: 10.2147/IDR.S21545. Epub 2011 Sep 21.

PMID:
22114508
[PubMed]
Free PMC Article
7.

Meningococcal group C and w135 immunological hyporesponsiveness in african toddlers.

Findlow H, Sow S, Borrow R, Tapia M, Haidara FC, Akinsola AK, Idoko OT, Diallo F, Adegbola R, Tang Y, Parulekar V, Chadha H, Mabey L, Holme D, Townsend K, Chaumont J, Laforce FM, Kulkarni PS, Marchetti E, Viviani S, Hassan-King M, Preziosi MP.

Clin Vaccine Immunol. 2011 Sep;18(9):1492-6. doi: 10.1128/CVI.05020-11. Epub 2011 Jul 13.

PMID:
21752951
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

An evaluation of emerging vaccines for childhood meningococcal disease.

Choudhuri D, Huda T, Theodoratou E, Nair H, Zgaga L, Falconer R, Luksic I, Johnson HL, Zhang JS, El Arifeen S, Nelson CB, Borrow R, Campbell H, Rudan I.

BMC Public Health. 2011 Apr 13;11 Suppl 3:S29. doi: 10.1186/1471-2458-11-S3-S29. Review.

PMID:
21501447
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Vaccine development against Neisseria meningitidis.

Vogel U, Claus H.

Microb Biotechnol. 2011 Jan;4(1):20-31. doi: 10.1111/j.1751-7915.2010.00178.x. Review.

PMID:
21255369
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine.

Kristiansen PA, Diomandé F, Wei SC, Ouédraogo R, Sangaré L, Sanou I, Kandolo D, Kaboré P, Clark TA, Ouédraogo AS, Absatou KB, Ouédraogo CD, Hassan-King M, Thomas JD, Hatcher C, Djingarey M, Messonnier N, Préziosi MP, LaForce M, Caugant DA.

Clin Vaccine Immunol. 2011 Mar;18(3):435-43. doi: 10.1128/CVI.00479-10. Epub 2011 Jan 12.

PMID:
21228139
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Meningococcal glycoconjugate vaccines.

Gasparini R, Panatto D.

Hum Vaccin. 2011 Feb;7(2):170-82. Epub 2011 Feb 1. Review.

PMID:
21178398
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Investigation of different group A immunoassays following one dose of meningococcal group A conjugate vaccine or A/C polysaccharide vaccine in adults.

Findlow H, Plikaytis BD, Aase A, Bash MC, Chadha H, Elie C, Laher G, Martinez J, Herstad T, Newton E, Viviani S, Papaspyridis C, Kulkarni P, Wilding M, Preziosi MP, Marchetti E, Hassan-King M, La Force FM, Carlone G, Borrow R.

Clin Vaccine Immunol. 2009 Jul;16(7):969-77. doi: 10.1128/CVI.00068-09. Epub 2009 May 27.

PMID:
19474264
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted with Alhydrogel, Montanide ISA 720 or AS02.

Roestenberg M, Remarque E, de Jonge E, Hermsen R, Blythman H, Leroy O, Imoukhuede E, Jepsen S, Ofori-Anyinam O, Faber B, Kocken CH, Arnold M, Walraven V, Teelen K, Roeffen W, de Mast Q, Ballou WR, Cohen J, Dubois MC, Ascarateil S, van der Ven A, Thomas A, Sauerwein R.

PLoS One. 2008;3(12):e3960. doi: 10.1371/journal.pone.0003960. Epub 2008 Dec 18.

PMID:
19093004
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk